Abbott Laboratories ABT
NYSE ABT
$105.42 -0.10 (-0.09%)
As of: Sep 9, 2026 · 3:30 PM EDT

Abbott Laboratories (ABT) FCF Payout Ratio Growth (1y) (2010 - 2026)

Analysis

Abbott Laboratories (ABT) FCF Payout Ratio Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (1y) (Qtr)
1 Abbott Laboratories 183.54 Bn 177.93 Bn 7.27 Bn -16.90%
2 Intuitive Surgical 124.70 Bn 119.48 Bn 1.96 Bn -
3 Medtronic 117.91 Bn 109.09 Bn 6.34 Bn -54.18%
4 Stryker 105.72 Bn 102.25 Bn 4.50 Bn -8.00%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -
6 Edwards Lifesciences 49.52 Bn 45.27 Bn 1.35 Bn -
7 Alcon 33.89 Bn 32.43 Bn 1.68 Bn -
8 Dexcom 32.10 Bn 30.15 Bn 830.00 Mn -
9 Steris 21.06 Bn 20.58 Bn 684.20 Mn 27.54%
10 Zimmer Biomet Holdings 18.26 Bn 17.85 Bn 1.54 Bn -18.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.90%
Mar 31, 2026 9.00%
Dec 31, 2025 -12.05%
Sep 30, 2025 0.74%
Jun 30, 2025 -1.10%
Mar 31, 2025 -27.95%
Dec 31, 2024 14.66%
Sep 30, 2024 -33.75%
Jun 30, 2024 -47.34%
Mar 31, 2024 30.85%
Dec 31, 2023 -18.90%
Sep 30, 2023 88.81%
Jun 30, 2023 213.66%
Mar 31, 2023 144.51%
Dec 31, 2022 47.43%
Sep 30, 2022 -0.13%
Jun 30, 2022 -12.93%
Mar 31, 2022 33.58%
Dec 31, 2021 58.29%
Sep 30, 2021 -12.14%